Ligand validation:6KY6

EPR: {5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid

EPR is a Ligand Of Interest in 6KY6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6KY6_EPR_A_302	2%	3%	0.291	0.63	2.79	3.29	2	9	1	0	62%	0.619
6KY6_EPR_B_302	2%	3%	0.294	0.594	2.91	3.37	4	9	0	0	62%	0.619
6KIY_EPR_A_302	8%	3%	0.215	0.761	2.72	3.62	2	9	1	0	62%	0.619
4JIH_EPR_A_401	33%	4%	0.156	0.901	1.77	3.96	2	11	1	0	62%	0.619
4JIR_EPR_A_401	30%	3%	0.154	0.883	1.69	4.16	2	11	1	0	62%	0.619

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.